Published in Obesity and Diabetes Week, November 1st, 2004
"Osteoprotegerin is a circulating osteoclastogenesis inhibitory factor and serum osteoprotegerin levels are elevated in hemodialysis patients. This study investigated whether osteoprotegerin levels correlated with various clinical parameters in hemodialysis patients. The subjects were 45 men and 37 women aged from 27 to 94 years (mean=60.4±13.9 years), and the duration of dialysis was 9-277 months (mean=89.5±64.7 months)," scientists writing in the journal Therapeutic Apheresis and Dialysis report.
"Serum osteoprotegerin levels were measured...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week